http://thunderhawkaviation.com/golfing-in-mexico-can-mean-a-unique-eco-friendly-experience.html
The Miami-based biotechnology developmentcompany OPK) is looking for money to support clinicapl trials in the ophthalmology field. “Wee are pleased to receive these funds and appreciate the confidencew of the investorsin Opko’s futur e success,” Opko Chairman and CEO Dr. Philli p Frost said in a news release. Three entities controlled by Taiwan-based Ruentex Group Chung Chia Co. Ltd., Grandtime Associates Ltd. and Gold Sino Assetd Ltd. – invested a combined $20 million in Opko. Ruentex’se operations include textiles, construction and development, finance, medical services, retail and education.
Miami-based tobacco companhy (NYSE: VGR) invested $5 milliohn in Opko. Frost beneficially owns 11.5 percent of Vectord Group, Opko stated in a filing on Two groups controlledby Greenwich, Conn.-based Oracle one of the world’s biggest health care focusex hedge funds, invested a combinedf $5 million in Opko. The remainin $1 million came from Nora Real which is controlled by formert directorCarlo Salvi. Frost got a spot on Teva’s boare after the Israeli company acquiredhis Miami-basef Opko shares were up 7 centsa to $1.27 in morninbg trading. No high/low information was available.
Комментариев нет:
Отправить комментарий